Dose-Dependent Effects of a Novel Selective EP(4) Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model

por Vater, Corina, Mehnert, Elisabeth, Bretschneider, Henriette, Bolte, Julia, Findeisen, Lisa, Matuszewski, Lucas-Maximilian, Zwingenberger, Stefan
Publicado 2021

A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein–2 and zoledro...

por Raina, Deepak Bushan, Matuszewski, Lucas-Maximilian, Vater, Corina, Bolte, Julia, Isaksson, Hanna, Lidgren, Lars, Tägil, Magnus, Zwingenberger, Stefan
Publicado 2020